DE69524622T2 - Verwendung von 1,5-benzodiazepinderivaten zur kontrolle des magen entleerens bei nicht insulinabhängigem diabetes mellitus - Google Patents

Verwendung von 1,5-benzodiazepinderivaten zur kontrolle des magen entleerens bei nicht insulinabhängigem diabetes mellitus

Info

Publication number
DE69524622T2
DE69524622T2 DE69524622T DE69524622T DE69524622T2 DE 69524622 T2 DE69524622 T2 DE 69524622T2 DE 69524622 T DE69524622 T DE 69524622T DE 69524622 T DE69524622 T DE 69524622T DE 69524622 T2 DE69524622 T2 DE 69524622T2
Authority
DE
Germany
Prior art keywords
insulin
stome
emptying
controlling
diabetes mellitus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69524622T
Other languages
English (en)
Other versions
DE69524622D1 (de
Inventor
Rochelle Hanley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of DE69524622D1 publication Critical patent/DE69524622D1/de
Application granted granted Critical
Publication of DE69524622T2 publication Critical patent/DE69524622T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69524622T 1994-10-14 1995-10-13 Verwendung von 1,5-benzodiazepinderivaten zur kontrolle des magen entleerens bei nicht insulinabhängigem diabetes mellitus Expired - Lifetime DE69524622T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9420747A GB9420747D0 (en) 1994-10-14 1994-10-14 1,5 benzodiazepine derivatives
PCT/US1995/012830 WO1996011691A1 (en) 1994-10-14 1995-10-13 Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus

Publications (2)

Publication Number Publication Date
DE69524622D1 DE69524622D1 (de) 2002-01-24
DE69524622T2 true DE69524622T2 (de) 2002-08-08

Family

ID=10762854

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69524622T Expired - Lifetime DE69524622T2 (de) 1994-10-14 1995-10-13 Verwendung von 1,5-benzodiazepinderivaten zur kontrolle des magen entleerens bei nicht insulinabhängigem diabetes mellitus

Country Status (10)

Country Link
EP (1) EP0785787B1 (de)
JP (1) JPH10511931A (de)
AT (1) ATE210446T1 (de)
AU (1) AU3736195A (de)
DE (1) DE69524622T2 (de)
DK (1) DK0785787T3 (de)
ES (1) ES2166406T3 (de)
GB (1) GB9420747D0 (de)
PT (1) PT785787E (de)
WO (1) WO1996011691A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750353A (en) * 1995-12-11 1998-05-12 New England Medical Center Hospitals, Inc. Assay for non-peptide agonists to peptide hormone receptors
IL124808A0 (en) 1995-12-11 1999-01-26 New England Medical Center Inc Assay for and uses of peptide hormone receptor ligands
CA2347938A1 (en) * 1998-10-20 2000-04-27 Takahiro Matsumoto 1,5-benzodiazepine compounds, their production and use
US9815850B2 (en) 2016-02-05 2017-11-14 Denali Therapeutics Inc. Compounds, compositions and methods
PL3552017T3 (pl) 2016-12-09 2022-08-08 Denali Therapeutics Inc. Związki użyteczne jako inhibitory RIPK1
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187154A (en) * 1990-12-13 1993-02-16 Board Of Regents, The University Of Texas System Diagnosis and treatment of humans with diabetes or at risk to develop diabetes
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
GB9420747D0 (en) 1994-11-30
ES2166406T3 (es) 2002-04-16
WO1996011691A1 (en) 1996-04-25
DE69524622D1 (de) 2002-01-24
PT785787E (pt) 2002-04-29
DK0785787T3 (da) 2002-03-11
AU3736195A (en) 1996-05-06
JPH10511931A (ja) 1998-11-17
EP0785787A1 (de) 1997-07-30
EP0785787B1 (de) 2001-12-12
ATE210446T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
NZ239514A (en) Oxazole-substituted hydroxy-urea and cyclised hydroxy-urea derivatives, intermediate compounds and medicaments
EP0453127A3 (en) Treatment of cataract with 15-keto-prostaglandin compounds
WO1996015784A3 (de) 2,2-dichloralkancarbonsäuren, verfahren zu ihrer herstellung diese enthaltende arzneimittel, und ihre verwendung zur behandlung der insulinresistenz
BG62620B1 (en) Carbocyclic compounds
ATE227710T1 (de) Oxazole derivate,ihre herstellung und verwendung
EE03392B1 (et) Aminoguanidiinkarboksülaadid insuliinisõltumatu suhkurtõve raviks
DE69524622T2 (de) Verwendung von 1,5-benzodiazepinderivaten zur kontrolle des magen entleerens bei nicht insulinabhängigem diabetes mellitus
DE69222459D1 (de) Thiazolidindionderivate, ihre Herstellung und Anwendung
EP0424156A3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
DE69007065T2 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
AU6418898A (en) Therapeutic agent for diabetes mellitus
EP1121932A4 (de) Heilmittel für augenerkrankungen
ITVI940062V0 (it) Soletta multistrato per la realizzazione di sottopiedi traspiranti, antiodore , da inserire all'interno di calzature.
DK0869785T3 (da) 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus
AU6991696A (en) 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents
KR960702835A (ko) 헤테로사이클릭 화학(Heterocyclic chemistry)
ES2195500T3 (es) Dereivados del 2-indanometanol y su utilizacion a titulo de ingredientes perfumantes.
MX9206339A (es) Nueva proteina inhibidora de trombina a partir de chinches de monte
PL348152A1 (en) Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus
DE59104129D1 (de) 2,2'-Thienyl-benzothiophene, ihre Herstellung und ihre Verwendung zur Bekämpfung von Schädlingen.
CA2276875A1 (en) Insecticidal oxadiazine compounds
DE69504220D1 (de) Sulfonamidodioxepane mit hypoglykämischen Eigenschaften, Methoden zu ihrer Herstellung, ihre Zwischenprodukte und Salze
RU97108937A (ru) Средство для гидропрепаровки поджелудочной железы при ее резекциях
AU6850090A (en) Imidazilyl propyl guanidine derivative, a process for its preparation and a pharmaceutical composition containing this compound
SI0869785T1 (en) 4-hydroxycoumarin-3-carboxamides for the treatment of non-insulin dependent diabetes mellitus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition